Sample Name:
EV.OT.122
Concentrate, Colorado Concentrate/Extract
Date Issued:
01/28/2024
- β-Caryophyllene 23.9665%
- α-Humulene 7.8537%
- Nerolidol 4.9175%
Sample Information
Cultivator / Manufacturer
Distributor
Share
Easily share a link to this results page with your friends, followers, or business partners.
Total Terpenoids: 54.2537%
1
β-Caryophyllene (23.9665%)
2
α-Humulene (7.8537%)
3
Nerolidol (4.9175%)
Safety Analysis - Summary
Pesticides: Pass
Mycotoxins: NT
Residual Solvents: NT
Heavy Metals: NT
Microbiology: NT
Foreign Material: NT
View Complete Test Results:
Terpenoid Analysis
Tested
Show More
Terpene analysis utilizing gas chromatography-flame ionization detection (GC-FID).
Method: QSP 1192 - Analysis of Terpenoids by GC-FID
Terpenoid Test Results
01/28/2024
Result Views
Swipe left on table to see additional columns
| Compound |
LOD/LOQ (mg/g) |
Measurement Uncertainty (mg/g) |
Result (mg/g) |
Result (%) |
|---|---|---|---|---|
| β-Caryophyllene | 0.004 / 0.012 | ±6.6387 | 239.665 | 23.9665 |
| α-Humulene | 0.009 / 0.029 | ±1.9634 | 78.537 | 7.8537 |
| Nerolidol | 0.006 / 0.019 | ±2.4096 | 49.175 | 4.9175 |
| α-Bisabolol | 0.008 / 0.026 | ±1.8885 | 45.507 | 4.5507 |
| Myrcene | 0.008 / 0.025 | ±0.2785 | 27.846 | 2.7846 |
| Guaiol | 0.009 / 0.030 | ±0.6449 | 17.571 | 1.7571 |
| Limonene | 0.005 / 0.016 | ±0.1512 | 13.620 | 1.3620 |
| trans-β-Farnesene | 0.008 / 0.025 | ±0.3580 | 12.972 | 1.2972 |
| Caryophyllene Oxide | 0.010 / 0.033 | ±0.4097 | 11.444 | 1.1444 |
| Linalool | 0.009 / 0.032 | ±0.3119 | 10.538 | 1.0538 |
| Terpineol | 0.009 / 0.031 | ±0.4067 | 8.508 | 0.8508 |
| α-Pinene | 0.005 / 0.017 | ±0.0436 | 6.504 | 0.6504 |
| β-Pinene | 0.004 / 0.014 | ±0.0395 | 4.439 | 0.4439 |
| Valencene | 0.009 / 0.030 | ±0.2149 | 4.010 | 0.4010 |
| Fenchol | 0.010 / 0.034 | ±0.0683 | 2.268 | 0.2268 |
| Eucalyptol | 0.006 / 0.018 | ±0.0383 | 1.942 | 0.1942 |
| Borneol | 0.005 / 0.016 | ±0.0599 | 1.833 | 0.1833 |
| β-Ocimene | 0.006 / 0.020 | ±0.0347 | 1.386 | 0.1386 |
| Sabinene Hydrate | 0.006 / 0.022 | ±0.0376 | 1.249 | 0.1249 |
| Δ3-Carene | 0.005 / 0.018 | ±0.0104 | 0.935 | 0.0935 |
| Citronellol | 0.003 / 0.010 | ±0.0220 | 0.580 | 0.0580 |
| Terpinolene | 0.008 / 0.026 | ±0.0069 | 0.436 | 0.0436 |
| Geraniol | 0.002 / 0.007 | ±0.0122 | 0.355 | 0.0355 |
| γ-Terpinene | 0.006 / 0.018 | ±0.0044 | 0.325 | 0.0325 |
| Fenchone | 0.009 / 0.028 | ±0.0064 | 0.282 | 0.0282 |
| Camphene | 0.005 / 0.015 | ±0.0015 | 0.162 | 0.0162 |
| Nerol | 0.003 / 0.011 | ±0.0041 | 0.120 | 0.0120 |
| p-Cymene | 0.005 / 0.016 | ±0.0024 | 0.117 | 0.0117 |
| α-Terpinene | 0.005 / 0.017 | ±0.0010 | 0.088 | 0.0088 |
| Isopulegol | 0.005 / 0.016 | ±0.0014 | 0.043 | 0.0043 |
| α-Phellandrene | 0.006 / 0.020 | ±0.0004 | 0.042 | 0.0042 |
| Sabinene | 0.004 / 0.014 | ±0.0004 | 0.038 | 0.0038 |
| Cedrol | 0.008 / 0.027 | N/A | ND | ND |
| Camphor | 0.006 / 0.019 | N/A | ND | ND |
| Menthol | 0.008 / 0.025 | N/A | ND | ND |
| Pulegone | 0.003 / 0.011 | N/A | ND | ND |
| Isoborneol | 0.004 / 0.012 | N/A | ND | ND |
| α-Cedrene | 0.005 / 0.016 | N/A | ND | ND |
| Geranyl Acetate | 0.004 / 0.014 | N/A | ND | ND |
| TOTAL | 542.537 mg/g | 54.2537% |
Learn more
Terpenoid analysis is crucial for differentiating between strains of cannabis, as terpenoids have a major influence on the medical and psychological effects of a plant. The relationship between cannabinoids and terpeneoids is known as the "entourage effect."
Pesticide Analysis
Pass
Show More
Pesticide and plant growth regulator analysis utilizing high-performance liquid chromatography-mass spectrometry (HPLC-MS) or gas chromatography-mass spectrometry (GC-MS).
*GC-MS utilized where indicated.
Method: QSP 1212 - Analysis of Pesticides and Mycotoxins by LC-MS or QSP 1213 - Analysis of Pesticides by GC-MS
Pesticide Test Results
01/27/2024
PASS
Swipe left on table to see additional columns
| Compound |
LOD/LOQ (μg/g) |
Action Limit (μg/g) |
Measurement Uncertainty (μg/g) |
Result (μg/g) |
Result |
|---|---|---|---|---|---|
| Abamectin | 0.032 / 0.097 | 0.25 | N/A | ND | Pass |
| Acephate | 0.006 / 0.018 | 0.05 | N/A | ND | Pass |
| Acequinocyl | 0.009 / 0.027 | ≥ LOQ | N/A | ND | Pass |
| Acetamiprid | 0.016 / 0.049 | 0.05 | N/A | ND | Pass |
| Aldicarb | 0.030 / 0.090 | 0.5 | N/A | ND | Pass |
| Allethrin | 0.030 / 0.092 | 0.1 | N/A | ND | Pass |
| Atrazine | 0.006 / 0.019 | ≥ LOQ | N/A | ND | Pass |
| Azadirachtin | 0.082 / 0.248 | 0.5 | N/A | ND | Pass |
| Azoxystrobin | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Benzovindiflupyr | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Bifenazate | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Bifenthrin | 0.021 / 0.064 | ≥ LOQ | N/A | ND | Pass |
| Boscalid | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Buprofezin‡ | 0.006 / 0.019 | ≥ LOQ | N/A | ND | Pass |
| Carbaryl | 0.007 / 0.020 | 0.025 | N/A | ND | Pass |
| Carbofuran | 0.003 / 0.008 | 0.01 | N/A | ND | Pass |
| Chlorantraniliprole | 0.006 / 0.018 | ≥ LOQ | N/A | ND | Pass |
| Chlorfenapyr* | 0.005 / 0.015 | 1.5 | N/A | ND | Pass |
| Chlorpyrifos | 0.013 / 0.039 | 0.5 | N/A | ND | Pass |
| cis-Permethrin | ± | 0.00 | |||
| Clofentezine | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Clothianidin | 0.008 / 0.025 | 0.025 | N/A | ND | Pass |
| Coumaphos | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Cyantraniliprole | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Cyfluthrin | 0.052 / 0.159 | ≥ LOQ | N/A | ND | Pass |
| Cypermethrin | 0.051 / 0.153 | ≥ LOQ | N/A | ND | Pass |
| Cyprodinil‡ | 0.003 / 0.008 | 0.01 | N/A | ND | Pass |
| Daminozide | 0.026 / 0.077 | ≥ LOQ | N/A | ND | Pass |
| Deltamethrin | 0.059 / 0.180 | ≥ LOQ | N/A | ND | Pass |
| Diazinon | 0.006 / 0.017 | ≥ LOQ | N/A | ND | Pass |
| Dichlorvos (DDVP) | 0.012 / 0.038 | 0.05 | N/A | ND | Pass |
| Dimethoate | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Dimethomorph | 0.016 / 0.050 | ≥ LOQ | N/A | ND | Pass |
| Dinotefuran | 0.010 / 0.030 | 0.05 | N/A | ND | Pass |
| Diuron | 0.013 / 0.040 | ≥ LOQ | N/A | ND | Pass |
| Dodemorph | 0.012 / 0.035 | ≥ LOQ | N/A | ND | Pass |
| Endosulfan sulfate†‡ | 0.016 / 0.048 | 2.5 | N/A | ND | Pass |
| Endosulfan-α*†‡ | 0.004 / 0.014 | 2.5 | N/A | ND | Pass |
| Endosulfan-β*†‡ | 0.006 / 0.019 | 2.5 | N/A | ND | Pass |
| Ethoprophos | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Etofenprox | 0.014 / 0.042 | ≥ LOQ | N/A | ND | Pass |
| Etoxazole | 0.007 / 0.020 | ≥ LOQ | N/A | ND | Pass |
| Etridiazole* | 0.002 / 0.005 | 0.15 | N/A | ND | Pass |
| Fenhexamid | 0.003 / 0.008 | ≥ LOQ | N/A | ND | Pass |
| Fenoxycarb | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Fenpyroximate | 0.007 / 0.020 | ≥ LOQ | N/A | ND | Pass |
| Fensulfothion | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Fenthion | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Fenvalerate‡ | 0.033 / 0.099 | ≥ LOQ | N/A | ND | Pass |
| Fipronil | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Flonicamid | 0.007 / 0.022 | 0.025 | N/A | ND | Pass |
| Fludioxonil | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Fluopyram‡ | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Hexythiazox | 0.003 / 0.010 | ≥ LOQ | N/A | ND | Pass |
| Imazalil | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Imidacloprid | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Iprodione | 0.077 / 0.233 | 0.5 | N/A | ND | Pass |
| Kinoprene | 0.077 / 0.233 | 1.25 | N/A | ND | Pass |
| Kresoxim-methyl | 0.006 / 0.019 | 0.15 | N/A | ND | Pass |
| λ-Cyhalothrin | 0.068 / 0.206 | ≥ LOQ | N/A | ND | Pass |
| Malathion | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Metalaxyl | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Methiocarb | 0.003 / 0.008 | 0.01 | N/A | ND | Pass |
| Methomyl | 0.008 / 0.025 | 0.025 | N/A | ND | Pass |
| Methoprene | 0.172 / 0.521 | ≥ LOQ | N/A | ND | Pass |
| Mevinphos | 0.008 / 0.024 | 0.025 | N/A | ND | Pass |
| MGK-264 | 0.015 / 0.047 | ≥ LOQ | N/A | ND | Pass |
| Myclobutanil | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Naled | 0.021 / 0.064 | ≥ LOQ | N/A | ND | Pass |
| Novaluron | 0.002 / 0.005 | 0.025 | N/A | ND | Pass |
| Oxamyl | 0.017 / 0.051 | 1.5 | N/A | ND | Pass |
| Paclobutrazol | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Parathion-methyl | 0.016 / 0.050 | ≥ LOQ | N/A | ND | Pass |
| Pentachloronitrobenzene (Quintozene)* | 0.004 / 0.012 | ≥ LOQ | N/A | ND | Pass |
| Permethrin | 0.056 / 0.168 | ≥ LOQ | N/A | ND | Pass |
| Phenothrin | 0.016 / 0.047 | ≥ LOQ | N/A | ND | Pass |
| Phosmet | 0.007 / 0.020 | ≥ LOQ | N/A | ND | Pass |
| Piperonyl Butoxide | 0.010 / 0.029 | 1.25 | N/A | ND | Pass |
| Pirimicarb | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Prallethrin | 0.015 / 0.046 | ≥ LOQ | N/A | ND | Pass |
| Propiconazole | 0.027 / 0.080 | ≥ LOQ | N/A | ND | Pass |
| Propoxur | 0.003 / 0.008 | 0.01 | N/A | ND | Pass |
| Pyraclostrobin | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Pyrethrins | 0.016 / 0.049 | ≥ LOQ | N/A | ND | Pass |
| Pyridaben | 0.005 / 0.017 | 0.02 | N/A | ND | Pass |
| Pyriproxyfen | 0.003 / 0.009 | ≥ LOQ | N/A | ND | Pass |
| Resmethrin | 0.013 / 0.039 | 0.05 | N/A | ND | Pass |
| Spinetoram | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Spinosad | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Spirodiclofen | 0.031 / 0.093 | ≥ LOQ | N/A | ND | Pass |
| Spiromesifen | 0.016 / 0.050 | ≥ LOQ | N/A | ND | Pass |
| Spirotetramat | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Spiroxamine | 0.020 / 0.062 | ≥ LOQ | N/A | ND | Pass |
| Tebuconazole | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Tebufenozide | 0.003 / 0.008 | 0.01 | N/A | ND | Pass |
| Teflubenzuron | 0.007 / 0.022 | 0.025 | N/A | ND | Pass |
| Tetrachlorvinphos | 0.003 / 0.008 | 0.01 | N/A | ND | Pass |
| Tetramethrin | 0.021 / 0.063 | ≥ LOQ | N/A | ND | Pass |
| Thiabendazole | 0.006 / 0.020 | ≥ LOQ | N/A | ND | Pass |
| Thiacloprid | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
| Thiamethoxam | 0.003 / 0.010 | 0.01 | N/A | ND | Pass |
| Thiophanate-methyl | 0.013 / 0.040 | ≥ LOQ | N/A | ND | Pass |
| trans-Permethrin | ± | 0.00 | |||
| Trifloxystrobin | 0.003 / 0.009 | 0.01 | N/A | ND | Pass |
COA ID: 240124N018-002
These results relate only to the sample included on this report. This report shall not be reproduced, except in full, without written approval of the laboratory.
Sample Certification: 6 CCR 1010-24 Colorado Hemp Product and Safe Harbor Hemp Product Regulations
Decision Rule: Statements of conformity (e.g. Pass/Fail) to specifications are made in this report without taking measurement uncertainty into account. Where statements of conformity are made in this report, the following decision rules are applied: PASS - Results within limits/specifications, FAIL - Results exceed limits/specifications.
References: limit of detection (LOD), limit of quantification (LOQ), not detected (ND), not tested (NT), μg/g = ppm, μg/kg = ppb
SC Laboratories California LLC. | 100 Pioneer Street, Suite E, Santa Cruz, CA 95060 | (866) 435-0709 | sclabs.com | CDPHE Certified | ISO/IES 17025:2017 PJLA Accreditation Number 87168
